PIK3CA and overgrowth syndrome: While most cases of overgrowth syndromes can be explained by gain-of-function mutations in PIK3CA, recent studies have reported PIK3R1 mutations in some patients with overgrowth syndromes and vascular malformations (Cottrell et al, 2021).